Study guide

6.2 Shunt Infections, CSF Correlates, Antigen and Molecular Methods

ASCP Microbiology Technologist M ASCP

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current M(ASCP) Exam Facts 1.2 CAT, Scoring, Retakes, and CMP 1.3 Eligibility Routes and Clinical Experience

2 Preanalytic: Collection and Transport

2.1 Patient Identification and Specimen Labeling 2.2 Specimen Collection, Sterile Technique, and Blood Cultures 2.3 Transport Devices, Atmosphere, Time, and Temperature

3 Preanalytic: Processing, Media, and Incubation

3.1 Prioritization, Rejection, and Specimen Preparation 3.2 Media Types, Components, and Selection 3.3 Inoculation, Incubation Conditions, and Slide Preparation

4 Preanalytic: Stains

4.1 Gram Stain: Procedure, Principle, and Interpretation 4.2 Acid-Fast and Modified Acid-Fast Stains 4.3 KOH, Calcofluor-White, Trichrome, Giemsa, and Acridine Orange

5 Bacteriology: Blood and Bone Marrow

5.1 Blood Culture Systems and Rapid Identification 5.2 Bloodstream Pathogens and Skin Flora Significance 5.3 Endocarditis, Bone Marrow Pathogens, and Pathogenicity

6 Bacteriology: CSF and Sterile Body Fluids

6.1 CSF Sources and Acute Meningitis Pathogens 6.2 Shunt Infections, CSF Correlates, Antigen and Molecular Methods 6.3 Sterile Body Fluids: Pathogens, Flora, and Molecular Methods

7 Bacteriology: Respiratory Tract

7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens 7.2 Cystic Fibrosis Pathogens and Quantitative Reporting 7.3 Upper Respiratory: Pharyngitis, Otitis, Sinusitis, Antigen/Molecular

8 Bacteriology: Gastrointestinal Tract

8.1 Enteric Pathogens: Culture and Colony Morphology 8.2 Clostridioides difficile, Shiga Toxin, and Serotyping 8.3 Helicobacter pylori Detection and GI Pathogenicity

9 Bacteriology: Skin, Soft Tissue, and Bone

9.1 Skin, Soft Tissue, and Bone Pathogens 9.2 Bite Wounds and Zoonotic Infections 9.3 SST Pathogenicity and Virulence Mechanisms

10 Bacteriology: Genital Tract and Urine

10.1 Genital Flora and Vaginitis Pathogens 10.2 Neisseria gonorrhoeae, Chlamydia trachomatis, GBS, and Mycoplasma 10.3 Urinary Pathogens, Colony Counts, and Urinalysis Correlation

11 Bacteriology: Identification Methods

11.1 Colony Morphology and Rapid Presumptive Tests 11.2 Conventional Biochemicals and Commercial Kits 11.3 Automated Methods, MALDI-TOF MS, Molecular, and 16S Sequencing

12 Bacteriology: Antimicrobial Susceptibility and Resistance

12.1 Microbroth Dilution, Disk Diffusion, and Gradient Diffusion 12.2 Phenotypic Detection of Resistance 12.3 Antibiotic Classes, Intrinsic Resistance, and Genetic Markers

13 Bacteriology: Resistance Screening and Select Agents

13.1 MRSA/MSSA, VRE, ESBL/CRE Screening 13.2 BSL-3 Pathogens and Select-Agent Presumptive Identification 13.3 Laboratory Response Network and Select-Agent Pathogenicity

14 Mycobacteriology and Nocardia

14.1 Specimens, Major Pathogens, and Disease States 14.2 Acid-Fast Reaction, Colony Morphology, and Growth Characteristics 14.3 Identification Methods, Direct Molecular Detection, and TB Therapy

15 Virology

15.1 Respiratory, Vesicle, Meningitis, and GI Viruses 15.2 Hepatitis, HIV, and Immunocompromised-Host Viruses 15.3 Direct Detection Methods and HPV Cervical Screening

16 Parasitology

16.1 Blood, Tissue, and Brain Protozoa 16.2 Intestinal/Urogenital Protozoa and Helminths 16.3 Microscopy, Antigen/Molecular Detection, Insects and Arthropods

17 Mycology

17.1 Yeasts: Candida, Cryptococcus, and Malassezia 17.2 Dimorphic Fungi and Dermatophytes 17.3 Mucorales, Hyaline Molds, Pneumocystis, and Identification Methods

18 Serology

18.1 Immunoglobulin Response and Antigen-Antibody Methods 18.2 Viral Serodiagnosis: Hepatitis, EBV, HIV, CMV, Rubella, Measles 18.3 Treponema, Borrelia, and TB Infection Serodiagnosis

19 Laboratory Operations: Postanalytic Procedures and Quality

19.1 Documentation, Critical Values, Corrected Reports, and Public Health 19.2 Quality Control, Root-Cause Analysis, and POCT 19.3 Proficiency Testing, Competency, and Accreditation

20 Laboratory Operations: Safety, Mathematics, and Instrumentation

20.1 Biosafety, PPE, Bloodborne Pathogens, and SDS 20.2 Emergencies and Packaging/Transportation of Specimens 20.3 Laboratory Mathematics and Instrumentation

6.2 Shunt Infections, CSF Correlates, Antigen and Molecular Methods

Key Takeaways Explain This Topic AI

Shunt and reservoir infections are led by biofilm skin organisms: coagulase-negative staphylococci (especially Staphylococcus epidermidis), Corynebacterium spp., Propionibacterium spp., and Cutibacterium spp., with Staphylococcus aureus when infection is more aggressive.

Do not automatically discard CoNS, coryneforms, or Cutibacterium from device CSF; incubate long enough, and include anaerobic culture when Cutibacterium acnes is in the differential.

Acute bacterial meningitis typically shows low CSF glucose, high protein, and neutrophilic pleocytosis; viral meningitis typically shows normal glucose and lymphocytic pleocytosis.

Historical bacterial latex antigen tests for pneumococcus, Haemophilus, and meningococcus have limited sensitivity and do not replace Gram stain or culture.

Multiplex meningitis/encephalitis PCR detects selected bacteria plus HSV and enterovirus in hours, but culture is still required for organisms off the panel and for susceptibility testing; a positive CSF Gram stain is a critical call.

Last updated: August 2026

Shunt and Reservoir Infections Are Not Community Meningitis

Outline II.B lists other Staphylococcus spp. , Corynebacterium spp. , Propionibacterium spp. , and Cutibacterium spp. as the indigenous organisms whose significance you must judge. In lumbar-puncture CSF from a patient without hardware, those organisms are usually skin contaminants . In ventriculoperitoneal shunts, ventriculoatrial shunts, external ventricular drains, and Ommaya reservoirs , they are the expected pathogens .

Staphylococcus epidermidis and other coagulase-negative staphylococci (CoNS) are the most common shunt-infection isolates. They adhere to silicone and plastic with biofilm : polysaccharide and protein matrix that shields organisms from neutrophils and from many antibiotics. Culture of CSF tapped from the reservoir may be positive while a lumbar puncture is still negative, because the infection is localized to the device. A single colony of CoNS from a community LP is often contamination; the same colony from a chronically febrile child with a VP shunt is a different conversation. Staphylococcus aureus still appears, usually with a more acute, purulent course and often with wound or tunnel infection.

Corynebacterium spp. (non-diphtheria coryneforms) and Cutibacterium acnes (formerly Propionibacterium acnes ) are anaerobic or aerotolerant Gram-positive rods that colonize sebaceous skin. They infect shunts and other neurosurgical hardware weeks to months after implantation. Colonies may not appear in 24 hours. C. acnes often needs anaerobic media and 5–7 days . If the laboratory discards "diphtheroids" at 48 hours of aerobic incubation only, it will miss a real shunt pathogen. The outline still prints Propionibacterium spp. alongside Cutibacterium spp. because older reports and some item banks use the former name; treat them as the same clinical problem on M.

Biofilm has two laboratory consequences. First, Gram stain of device fluid can be positive when quantitative growth is modest. Second, device removal is often required for cure because antibiotics penetrate biofilm poorly—the microbiologist's job is still to recover and identify the organism, not to decide surgery, but the identification must not be watered down as "probable contaminant" in the report without the source being obvious.

Exam scenario. CSF from a VP-shunt tap grows white, catalase-positive, coagulase-negative colonies after 48 hours, and the cytospin showed rare Gram-positive cocci in clusters with few neutrophils. The correct exam move is to identify the CoNS and communicate the result as a shunt-associated isolate, not to reculture only the next LP because "CoNS is always skin flora."

Correlate Chemistry and Cell Count With the Smear

M asks you to correlate culture with CSF glucose, protein, and cell count . Use the pattern, not a single cutoff memorized without the serum glucose.

Pattern Glucose Protein Cells Gram stain

Acute bacterial meningitis Low (often <40 mg/dL or CSF:serum ratio <0.4–0.5) High (often >100 mg/dL) Neutrophilic (PMN) pleocytosis, WBC often hundreds to thousands May show organisms

Viral meningitis / most encephalitis Normal Normal or mildly high Lymphocytic pleocytosis, WBC often tens to a few hundred Negative

Early bacterial or partially treated bacterial May still be low High Can start PMN then shift Often negative after antibiotics

Mycobacterial or fungal (not the focus of II.B, but a distractor) Low Very high Lymphocytic Ordinary Gram stain negative

Shunt biofilm infection Variable; may be closer to normal than fulminant pneumococcal disease Variable Often fewer PMNs than community bacterial meningitis CoNS, coryneforms, or Cutibacterium

Low glucose in bacterial meningitis happens because organisms and neutrophils consume glucose and because transport at the choroid plexus is impaired. High protein reflects blood–brain barrier leakage. PMN pleocytosis is the acute bacterial fingerprint; lymphocytic pleocytosis is the viral fingerprint. Exceptions exist (early enterovirus can look neutrophilic for a day; Listeria can have a mixed or lymphocytic picture), which is why the Gram stain and culture still run even when the chemistry is "viral."

Do not diagnose bacterial meningitis from a high protein alone in a bloody traumatic tap; correct for serum values and look at the cytospin. Do not call a shunt infection "ruled out" because the glucose is normal.

Antigen Detection: Historical Latex, Limited Sensitivity

Older laboratories used latex agglutination on CSF supernatant for S. pneumoniae , H. influenzae type b, N. meningitidis (selected serogroups), GBS, and E. coli K1. The outline still lists antigen detection , so you must know what the test was and why it is no longer a stand-alone tool.

Sensitivity is limited , especially after antibiotics, with low organism load, and with meningococcal serogroups the kit does not cover. Specificity problems include rheumatoid-factor-like interference and capsule cross-reactions (K1 E. coli and meningococcal group B). A negative latex test never cancels a Gram stain or culture. A positive latex test does not identify a colony for susceptibility testing. Cryptococcal antigen remains clinically useful, but that is a mycology method, not a substitute for the bacterial latex kits described here.

If an item stem offers latex antigen as the next step after a negative cytospin in untreated pneumococcal disease, the better next steps are culture, broth, and molecular detection , not reliance on latex.

Loading diagram... CSF correlates, shunt isolates, and when to call or add PCR

Order-of-magnitude CSF teaching values for cell count, protein, and glucose

Molecular Methods: Multiplex Meningitis/Encephalitis PCR

Syndromic meningitis/encephalitis PCR panels (the commercial example most laboratories use is a multiplex cartridge on CSF) detect a fixed list of bacteria and viruses in about an hour. Bacterial targets typically include S. pneumoniae , N. meningitidis , H. influenzae , L. monocytogenes , S. agalactiae (GBS), and E. coli . Viral targets that the M outline cares about in this chapter are HSV and enterovirus ; panels also commonly include VZV, CMV, HHV-6, and human parechovirus, plus Cryptococcus neoformans/gattii . That list is why a "viral-pattern" CSF still gets a molecular test: HSV encephalitis is treatable and enterovirus explains many lymphocytic meningitides in children.

Know the limits as tightly as the targets. PCR does not detect every bacterium that can sit in CSF: CoNS, C. acnes , Corynebacterium , S. aureus (on some versions), and many Enterobacteriaceae other than E. coli may be absent. A negative panel in a shunt patient therefore means nothing about biofilm infection. PCR does not produce an isolate for antimicrobial susceptibility testing . A pneumococcal PCR-positive, culture-negative specimen in a pretreated patient is useful for diagnosis and still leaves the physician without an MIC. False positives occur (HHV-6 latency in leukocytes is the usual teaching example). False negatives occur when the organism is off-panel or below the limit of detection.

Use PCR with Gram stain and culture, not instead of them. If the cytospin already shows lancet-shaped diplococci, you still plate CHOC and BAP even though the pneumococcal PCR is pending.

Critically Communicate the Gram Stain

A positive CSF Gram stain is a critical result. Call it as soon as it is read, before overnight growth, because empiric meningitis therapy is hours-sensitive. The report should name the morphology , not a species guess presented as fact: "Gram-negative diplococci" is the stain result; N. meningitidis is the leading interpretation in an adolescent, confirmed by culture or PCR. Document who was notified and the time . Positive cultures for the acute pathogens, and PCR positives for treatable targets such as HSV or meningococcus, follow the same critical-call pathway in most laboratories.

Shunt isolates deserve a phone call as well when the clinician may still think "contaminant." The outline's indigenous list is a trap for the candidate who auto-rejects CoNS. Communicate the source (shunt tap versus LP), the Gram morphology, and that biofilm organisms are significant in that context.

Exam scenario. CSF glucose 18 mg/dL, protein 220 mg/dL, WBC 2,400 with 90% neutrophils, cytospin with Gram-negative diplococci: call immediately, plate in CO2, add the multiplex panel if it is the laboratory's STAT menu, and do not wait for latex antigen to "confirm" meningococcus. Exam scenario. VP-shunt fluid with glucose 55 mg/dL, protein 60 mg/dL, WBC 80, rare Gram-positive rods on smear that grow anaerobically on day 5 as C. acnes : that is a shunt infection pattern, not a reason to change the report to "mixed skin flora, suggest reculture."